Common to these interactions is adrenergic signaling as ADRB2 is expressed both on tumor cells and endothelial cells and activation of adrenergic signaling promotes tumor cell survival, drive angiogenesis through several downstream signaling pathways (Figure 1A). The gene discussed is ADRB2; the disease is neoplasm.